Literature DB >> 10331605

Reduced mRNA for G3BP in fragile X cells: evidence of FMR1 gene regulation.

N Zhong1, W Ju, D Nelson, C Dobkin, W T Brown.   

Abstract

Although fragile X syndrome is caused by the absence of fragile X gene expression, little is known about the pathogenic processes underlying the mental retardation. Recent findings that the fragile X protein, FMRP, contains RNA binding motifs and nuclear transport signals and associates with ribosomes suggest that FMRP may be involved in either mRNA processing, transport, or translation. To test the hypothesis that absence of FMRP may affect the processing of specific transcripts, we have used an RNA differential display assay (RDDA) to identify differentially expressed transcripts in lymphoblast lines derived from fragile X syndrome patients. A 0.9-kb cDNA fragment that showed reduced expression in a fragile X lymphoblast cell line was found to be identical to G3BP (Ras-GTPase-Activating protein SH3-domain-binding protein). Quantitative reverse transcriptase-polymerase chain reaction showed that the expressed levels of G3BP mRNA in fragile X lymphoblast cell lines were significantly less than controls. Our results indicate that G3BP mRNA may be regulated by FMRP and supports the hypothesis that FMRP may modulate the transcription of specific transcripts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331605     DOI: 10.1002/(sici)1096-8628(19990528)84:3<268::aid-ajmg20>3.0.co;2-#

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome.

Authors:  Hailan Hu; Yi Qin; Genrieta Bochorishvili; Yinghua Zhu; Linda van Aelst; J Julius Zhu
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

2.  Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins.

Authors:  Regina Fischer-Kešo; Sonja Breuninger; Sarah Hofmann; Manuela Henn; Theresa Röhrig; Philipp Ströbel; Georg Stoecklin; Ilse Hofmann
Journal:  Mol Cell Biol       Date:  2014-09-15       Impact factor: 4.272

3.  Protein methylation and stress granules: posttranslational remodeler or innocent bystander?

Authors:  Wen Xie; Robert B Denman
Journal:  Mol Biol Int       Date:  2011-02-24

4.  Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome.

Authors:  John M Tauber; Phillip A Vanlandingham; Bing Zhang
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

5.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability.

Authors:  Francesca Zalfa; Boris Eleuteri; Kirsten S Dickson; Valentina Mercaldo; Silvia De Rubeis; Alessandra di Penta; Elisabetta Tabolacci; Pietro Chiurazzi; Giovanni Neri; Seth G N Grant; Claudia Bagni
Journal:  Nat Neurosci       Date:  2007-04-08       Impact factor: 24.884

6.  The guanine-quadruplex structure in the human c-myc gene's promoter is converted into B-DNA form by the human poly(ADP-ribose)polymerase-1.

Authors:  Anna Fekete; Erzsebet Kenesi; Eva Hunyadi-Gulyas; Hajnalka Durgo; Barbara Berko; Zsuzsanna A Dunai; Pal I Bauer
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

7.  Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.

Authors:  Chae-Seok Lim; Elizabeth T Hoang; Kenneth E Viar; Ruth L Stornetta; Michael M Scott; J Julius Zhu
Journal:  Genes Dev       Date:  2014-02-01       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.